Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in California
944
mi
from 98109
Mission Hills, CA
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in California
944
mi
from 98109
Mission Hills, CA
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Colorado Springs, Colorado
1067
mi
from 98109
Colorado Springs, CO
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Colorado Springs, Colorado
1067
mi
from 98109
Colorado Springs, CO
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Miami, Florida
2727
mi
from 98109
Miami, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Miami, Florida
2727
mi
from 98109
Miami, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in St. Augustine, FL
2464
mi
from 98109
Saint Augustine, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in St. Augustine, FL
2464
mi
from 98109
Saint Augustine, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in New York, New York
2402
mi
from 98109
New York, NY
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in New York, New York
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in North Carolina
2187
mi
from 98109
Asheville, NC
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in North Carolina
2187
mi
from 98109
Asheville, NC
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Dothan, Alabama
mi
from 98109
Dothan, AL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Dothan, Alabama
mi
from 98109
Dothan, AL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Lauderdale Lakes, FL
mi
from 98109
Lauderdale Lakes, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Lauderdale Lakes, FL
mi
from 98109
Lauderdale Lakes, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Maitland, FL
mi
from 98109
Maitland, FL
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Maitland, FL
mi
from 98109
Maitland, FL
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Atlanta, GA
mi
from 98109
Atlanta, GA
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Atlanta, GA
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Minneapolis, MN
mi
from 98109
Minneapolis, MN
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Minneapolis, MN
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated:  12/31/1969
One (1) Location in Greenville, SC
mi
from 98109
Greenville, SC
Fecal Calprotectin Collection Protocol
CALFE Stool Sample Collection Protocol
Status: Enrolling
Updated: 12/31/1969
One (1) Location in Greenville, SC
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome
Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome
Status: Enrolling
Updated:  12/31/1969
Cardinal Glennon Children's Medical Center
1719
mi
from 98109
Saint Louis, MO
Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome
Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome
Status: Enrolling
Updated: 12/31/1969
Cardinal Glennon Children's Medical Center
1719
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Texas Clinical Research Institute
1670
mi
from 98109
Arlington, TX
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Texas Clinical Research Institute
1670
mi
from 98109
Arlington, TX
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Texas Liver Institute
1786
mi
from 98109
San Antonio, TX
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Texas Liver Institute
1786
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Radiant Research Incorporated
1128
mi
from 98109
Chandler, AZ
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Radiant Research Incorporated
1128
mi
from 98109
Chandler, AZ
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Central Arizona Medical Associates, PC
1124
mi
from 98109
Mesa, AZ
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Central Arizona Medical Associates, PC
1124
mi
from 98109
Mesa, AZ
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Anaheim Clinical Trials, LLC
980
mi
from 98109
Anaheim, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Anaheim Clinical Trials, LLC
980
mi
from 98109
Anaheim, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
eStudy Site, Chula Vista
1075
mi
from 98109
Chula Vista, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
eStudy Site, Chula Vista
1075
mi
from 98109
Chula Vista, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Southern California Research Center
1066
mi
from 98109
Coronado, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Southern California Research Center
1066
mi
from 98109
Coronado, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Fresno Clinical Research Center (FCRC)
757
mi
from 98109
Fresno, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Fresno Clinical Research Center (FCRC)
757
mi
from 98109
Fresno, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Clinical Trials Research
605
mi
from 98109
Lincoln, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Clinical Trials Research
605
mi
from 98109
Lincoln, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
National Research Institute
961
mi
from 98109
Los Angeles, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
National Research Institute
961
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Catalina Research Institute, LLC
967
mi
from 98109
Montclair, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Catalina Research Institute, LLC
967
mi
from 98109
Montclair, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Inland Empire Liver Foundation
965
mi
from 98109
Rialto, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Inland Empire Liver Foundation
965
mi
from 98109
Rialto, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Southern California Transplantation Institute Research Foundation
mi
from 98109
San Clemente, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Southern California Transplantation Institute Research Foundation
mi
from 98109
San Clemente, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Precision Research Institute, LLC
1065
mi
from 98109
San Diego, CA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Precision Research Institute, LLC
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Peak Gastroenterology Associates
1067
mi
from 98109
Colorado Springs, CO
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Peak Gastroenterology Associates
1067
mi
from 98109
Colorado Springs, CO
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc. / Colorado Springs Family Practice
1067
mi
from 98109
Colorado Springs, CO
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc. / Colorado Springs Family Practice
1067
mi
from 98109
Colorado Springs, CO
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
South Denver Gastroenterology
1024
mi
from 98109
Englewood, CO
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
South Denver Gastroenterology
1024
mi
from 98109
Englewood, CO
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Avail Clinical Research
2526
mi
from 98109
DeLand, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Avail Clinical Research
2526
mi
from 98109
DeLand, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Fleming Island Center for Clinical Research
2460
mi
from 98109
Fleming Island, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Fleming Island Center for Clinical Research
2460
mi
from 98109
Fleming Island, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Westside Center for Clinical Research
2452
mi
from 98109
Jacksonville, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Westside Center for Clinical Research
2452
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Jacksonville Center for Clinical Research
2456
mi
from 98109
Jacksonville, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Jacksonville Center for Clinical Research
2456
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Jacksonville Center for Endoscopy - Southside ; Borland Groover Clinic
mi
from 98109
Jacksonville, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Jacksonville Center for Endoscopy - Southside ; Borland Groover Clinic
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Precision Clinical Research
2711
mi
from 98109
Lauderdale Lakes, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Precision Clinical Research
2711
mi
from 98109
Lauderdale Lakes, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Ocean Blue Medical Research Center, Inc.
2725
mi
from 98109
Miami Springs, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Ocean Blue Medical Research Center, Inc.
2725
mi
from 98109
Miami Springs, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Homestead Medical Research
mi
from 98109
Miami, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Homestead Medical Research
mi
from 98109
Miami, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Florida Advanced Medical Research, Inc.
mi
from 98109
Miami, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Florida Advanced Medical Research, Inc.
mi
from 98109
Miami, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc
2549
mi
from 98109
Orlando, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc
2549
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Advanced Gastroenterology Associates, LLC
2508
mi
from 98109
Palm Harbor, FL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Advanced Gastroenterology Associates, LLC
2508
mi
from 98109
Palm Harbor, FL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Piedmont Atlanta Hospital
2177
mi
from 98109
Atlanta, GA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Piedmont Atlanta Hospital
2177
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Gastrointestinal Specialists of Georgia
2164
mi
from 98109
Marietta, GA
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Gastrointestinal Specialists of Georgia
2164
mi
from 98109
Marietta, GA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Feinberg School of Medicine, Northwestern University
1732
mi
from 98109
Chicago, IL
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Feinberg School of Medicine, Northwestern University
1732
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Midwest Institute for Clinical Research
1862
mi
from 98109
Indianapolis, IN
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Midwest Institute for Clinical Research
1862
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center
2328
mi
from 98109
Baltimore, MD
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Digestive Disease Associates, PA
2323
mi
from 98109
Catonsville, MD
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Digestive Disease Associates, PA
2323
mi
from 98109
Catonsville, MD
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
1903
mi
from 98109
Ann Arbor, MI
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Kansas City Research Institute
1505
mi
from 98109
Kansas City, MO
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Kansas City Research Institute
1505
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated:  12/31/1969
Saint Louis University
1718
mi
from 98109
Saint Louis, MO
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis
A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Status: Enrolling
Updated: 12/31/1969
Saint Louis University
1718
mi
from 98109
Saint Louis, MO
Click here to add this to my saved trials